Top compounds associated with response to NFU1


Feature Type Standardized
Nominal ANOVA
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.12 0.02
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.12 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.082 0.02
mRNA Doxorubicin gCSI pan-cancer AAC 0.11 0.02
mRNA barasertib CTRPv2 pan-cancer AAC -0.074 0.02
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.084 0.02
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.078 0.02
mRNA niclosamide CTRPv2 pan-cancer AAC 0.081 0.03
Download CSV